Low Barthel index score is a poor prognostic factor for newly diagnosed multiple myeloma patients

被引:2
|
作者
Geng, Chuanying [1 ]
Yang, Guangzhong [1 ]
Zhou, Huixing [1 ]
Wang, Huijuan [1 ]
Li, Yanchen [1 ]
Leng, Yun [1 ]
Zhang, Zhiyao [1 ]
Jian, Yuan [1 ]
Chen, Wenming [1 ]
机构
[1] Capital Med Univ, Beijing Chaoyang Hosp, Dept Hematol, Beijing 100020, Peoples R China
关键词
Multiple myeloma; Barthel index; Survival; Prognostic factors; GERIATRIC-ASSESSMENT; CRITERIA; FRAILTY;
D O I
10.1007/s10238-023-01002-7
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The basic activities of daily life may affect the prognosis of multiple myeloma (MM) patients and the Barthel index (BI) is currently the most widely used tool to evaluate basic activities of daily life, but few studies have evaluated its prognostic value in MM. We retrospectively enrolled patients with newly diagnosed MM and analyzed the association between the BI and the survival of newly diagnosed MM patients. We totally analyzed 538 patients and found that median overall survival (OS) and progression-free survival (PFS) were significantly shorter in the low BI (<= 85) group compared with the high BI (> 85) group. Univariate Cox proportional hazards regression analysis showed that the low BI was associated with shorter OS and PFS. It was also confirmed that the low BI was poor prognostic factor for OS and PFS in multivariable analyses. In the propensity score matching analysis, patients with low BI also had shorter OS and PFS. Our study suggested that the low BI was a poor prognostic factor for patients with newly diagnosed MM.
引用
收藏
页码:2593 / 2600
页数:8
相关论文
共 50 条
  • [21] Chromosome 1q21 Aberrations Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients
    Wang, Tongtong
    Geng, Chuanying
    Yang, Guangzhong
    Zhou, Huixing
    Zhang, Zhiyao
    Jian, Yuan
    Chen, Wenming
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2024, 38 (17-18)
  • [22] Morphologic Classification Is an Important Prognostic Factor in Patients with Newly Diagnosed Multiple Myeloma Treated with Bortezomib or Lenalidomide
    Takakuwa, Teruhito
    Araki, Taku
    Nakamura, Koji
    Fukuyama, Tomoko
    Miura, Akiko
    Fujitani, Yotaro
    Hisanabe, Akari
    Kaieda, Anna
    Fukada, Erina
    Yamamura, Ryosuke
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2020, 50 (03): : 333 - 341
  • [23] Echocardiography-defined pulmonary hypertension is an adverse prognostic factor for newly diagnosed multiple myeloma patients
    Jian, Yuan
    Zhou, Huixing
    Wang, Yidan
    Zhang, Zhiyao
    Yang, Guangzhong
    Geng, Chuanying
    Tian, Ying
    Gao, Wen
    Chen, Wenming
    CANCER MEDICINE, 2022, 11 (22): : 4182 - 4192
  • [24] A Hematopoietic Score Predicts Survival in Newly Diagnosed Multiple Myeloma Patients.
    Al Saleh, Abdullah S.
    Sidiqi, M. Hasib
    Dispenzieri, Angela
    Muchtar, Eli
    Buadi, Francis
    Warsame, Rahma
    Lacy, Martha
    Dingli, David
    Leung, Nelson
    Gonsalves, Wilson
    Kapoor, Prashant
    Kourelis, Taxiarchis
    Gertz, Morie A.
    Go, Ronald
    Kyle, Robert
    Rajkumar, S. Vincent
    Kumar, Shaji
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E85 - E86
  • [25] Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple Myeloma
    He, JingSong
    Yue, XiaoYan
    He, DongHua
    Zhao, Yi
    Yang, Yang
    Zheng, GaoFeng
    Zhang, Enfan
    Han, XiaoYan
    Wu, WenJun
    Yang, Li
    Chen, Jing
    Cai, Zhen
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [26] Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma
    Chun-Kuang Tsai
    Chiu-Mei Yeh
    Te-Lin Hsu
    Chia-Ju Li
    Chian Tin
    Liang-Tsai Hsiao
    Yao-Chung Liu
    Hao-Yuan Wang
    Po-Shen Ko
    Po-Min Chen
    Jin-Hwang Liu
    Jyh-Pyng Gau
    Chia-Jen Liu
    Supportive Care in Cancer, 2021, 29 : 3991 - 3999
  • [27] Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma
    Tsai, Chun-Kuang
    Yeh, Chiu-Mei
    Hsu, Te-Lin
    Li, Chia-Ju
    Tin, Chian
    Hsiao, Liang-Tsai
    Liu, Yao-Chung
    Wang, Hao-Yuan
    Ko, Po-Shen
    Chen, Po-Min
    Liu, Jin-Hwang
    Gau, Jyh-Pyng
    Liu, Chia-Jen
    SUPPORTIVE CARE IN CANCER, 2021, 29 (07) : 3991 - 3999
  • [28] Prognostic Impact of t(11;14) in Newly Diagnosed Patients With Multiple Myeloma
    Ntanasis-Stathopoulos, Ioannis
    Terpos, Evangelos
    Briasoulis, Alexandros
    Malandrakis, Panagiotis
    Fotiou, Despina
    Migkou, Magdalini
    Spiliopoulou, Vasiliki
    Theodorakakou, Foteini
    Filippatos, Charalampos
    Roussou, Maria
    Kanellias, Nikolaos
    Eleftherakis-Papaiakovou, Evangelos
    Kastritis, Efstathios
    Dimopoulos, Meletios
    Gavriatopoulou, Maria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S238 - S239
  • [29] Development and Analysis of a Weighed Prognostic Model in Newly Diagnosed Multiple Myeloma Patients
    Mao, Xue-Han
    Xu, Yan
    Yan, Yuting
    Liu, Jiahui
    Fan, Huishou
    Sui, Weiwei
    Deng, Shuhui
    Du, Chenxing
    Zou, Dehui
    Qiu, Lugui
    An, Gang
    BLOOD, 2020, 136
  • [30] Prognostic impact of renal failure recovery in patients with newly diagnosed multiple myeloma
    Pena, Camila
    Valladares, Ximena
    Gajardo, Claudia
    Russo, Moises
    Morales, Alvaro
    Correa, Gonzalo
    Valjalo, Ricardo
    REVISTA MEDICA DE CHILE, 2019, 147 (11) : 1374 - 1381